Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celgene Corporation Will Announce Third Quarter Financial Results on October 24, 2002.


Business Editors

WARREN, N.J.--(BUSINESS WIRE)--Oct. 16, 2002

Celgene Celgene Corporation NASDAQ: CELG is a manufacturer of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey.  Corporation (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CELG) will announce its third quarter financial results on Thursday Thursday: see week. , October 24, 2002 by press release before the market opens. Celgene's management will host a conference call and live audio webcast at 9:00 AM ET to fully discuss the financial results and other business results.

The webcast will be available in the investor relations Investor relations

The process by which the corporation communicates with its investors.
 section of the Company's website at www.celgene.com and will be archived for two weeks. An audio replay of the conference call will be available from noon ET, October 24, 2002 until midnight ET, October 27, 2002. To access the replay, please dial 1-800-633-8284 and enter Reservation Number 20968501.

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors Institutional Investor

A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions.
 can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

Celgene Corporation, headquartered in Warren, New Jersey, is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel drugs for treatment of cancer and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation
disease - an impairment of health or a condition of abnormal functioning

NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants;
 through gene and protein regulation.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 16, 2002
Words:215
Previous Article:Mack-Cali Realty Corporation Announces Third Quarter 2002 Earnings Release Date; Conference Call To Be Held With Management.
Next Article:HP Expands Mobile Print Offerings to Make Wireless Printing Simple; Company Drives Growing Market for Mobile Printing with New Solutions, Technology...
Topics:



Related Articles
Celgene Corporation to Acquire Signal Pharmaceuticals, Inc.; Celgene Drug Discovery Expands Into Gene Regulation.
Celgene Corporation Will Announce Second Quarter Financial Results on July 25, 2002.
Celgene Corporation Will Announce Fourth Quarter and Full Year Financial Results on January 30, 2003.
Celgene Corporation Will Announce First Quarter Financial Results on April 24, 2003.
Celgene Corporation to Announce Third Quarter Financial and Operational Results on October 23, 2003.
Celgene Corporation to Announce Fourth Quarter and Year-End 2003 Financial and Operational Results on January 29, 2004.
Celgene Corporation to Announce First Quarter Financial and Operational Results on April 22, 2004.
Celgene Corporation to Announce Second Quarter Financial and Operational Results on July 22, 2004.
Celgene Corporation Third Quarter 2004 Earnings Conference Call.
Celgene Corporation Second Quarter 2005 Earnings Conference Call.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles